Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 84Thoracic 9Breast 9Dermatologic 6Head & Neck 5Genitourinary 5Gastrointestinal 5Sarcoma 4Endocrine 3Lymphoid 2NET 1Gynecologic 1

Conditions

Neuroendocrine Tumors 28Neoplasms 4Melanoma 4Carcinoma, Neuroendocrine 4Sarcoma 3Pheochromocytoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Liver Neoplasms 3Gastro-enteropancreatic neuroendocrine tumor 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Carcinoid Tumor 3Breast Neoplasms 3Thyroid Neoplasms 2Thymus Neoplasms 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Paraganglioma 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Multiple Myeloma 2Meningioma 2Lung Neoplasms 2Insulinoma 2Head and Neck Neoplasms 2

Interventions

entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × NET × 30 days × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡